Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Current Liabilities (2020 - 2022)

Atea Pharmaceuticals has reported Total Current Liabilities over the past 3 years, most recently at $15.6 million for Q3 2022.

  • Quarterly results put Total Current Liabilities at $15.6 million for Q3 2022, down 94.03% from a year ago — trailing twelve months through Sep 2022 was $15.6 million (down 94.03% YoY), and the annual figure for FY2021 was $56.9 million, down 81.99%.
  • Total Current Liabilities for Q3 2022 was $15.6 million at Atea Pharmaceuticals, down from $25.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for AVIR hit a ceiling of $315.8 million in Q4 2020 and a floor of $10.8 million in Q3 2020.
  • Median Total Current Liabilities over the past 3 years was $56.9 million (2021), compared with a mean of $138.1 million.
  • Biggest five-year swings in Total Current Liabilities: surged 2322.82% in 2021 and later tumbled 94.03% in 2022.
  • Atea Pharmaceuticals' Total Current Liabilities stood at $315.8 million in 2020, then crashed by 81.99% to $56.9 million in 2021, then tumbled by 72.52% to $15.6 million in 2022.
  • The last three reported values for Total Current Liabilities were $15.6 million (Q3 2022), $25.1 million (Q2 2022), and $28.6 million (Q1 2022) per Business Quant data.